GlassScriptPhysician profile
Laurel A Bondi
NPI 1932296555
$5,090.22
in general payments reported to CMS, 2019-2025
24 companies · $569 in 2025
The $569 reported for 2025 was more than what 75% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,297 · 2020: $541 · 2021: $632 · 2022: $183 · 2023: $417 · 2024: $1,452 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,801 · Travel and Lodging: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,801.27 |
| Travel and Lodging | $636.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $1,046.91 | 2019-2023 | |
| Treace Medical Concepts, INC. | $769.54 | 2020-2025 | |
| Medical Device Business Services, INC. | $691.17 | 2024 | |
| Lifenet Health | $321.46 | 2023-2024 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $306.21 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $306.17 | 2019-2021 | |
| Depuy Synthes Sales INC. | $221.50 | 2022-2024 | Hammerlock, Motoband, N/A |
| Nevro Corp. | $149.97 | 2022 | |
| Stryker Corporation | $141.78 | 2019-2024 | Actishield, N/A, Citrefix |
| Misonix INC | $128.86 | 2021 | |
| Acera Surgical, INC. | $126.58 | 2021-2025 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $109.33 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $106.62 | 2025 | Jublia |
| Surgenex LLC | $104.45 | 2025 | Pellograft, Surmatrix, Surgraft |
| Medline Industries LP | $102.28 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $94.39 | 2024 | Nuzyra |
| Kerecis Limited | $92.83 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $75.81 | 2023-2024 | Theragenesis Bilayer Wound Matrix, Exogen Ultrasound Bone Healing System |
| Mimedx Group, INC. | $46.07 | 2024 | |
| Smith+Nephew, INC. | $34.03 | 2019-2023 | Collagenase Santyl, Regranex |
| Biocomposites INC | $32.71 | 2025 | Stimulan |
| Zimmer Biomet Holdings, INC. | $30.51 | 2019 | |
| Grt US Holding, INC. | $29.16 | 2020-2021 | |
| Access Pro Medical, LLC | $21.88 | 2025 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Bondi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.